Dr. Sandy Srinivas explains how age, comorbidities and medications influence personalized prostate cancer treatment decisions ...

Fraser Symmans explains how ctDNA is replacing CTCs to monitor breast cancer, detect mutations and track minimal residual ...

MacDonald draws on her unique dual perspective to advocate for better patient education. Despite a decade of medical ...

Most surgical candidates, including many with prior thoracic or abdominal operations, can undergo minimally invasive ...

Receiving a diagnosis of stage 1 urothelial carcinoma (bladder cancer) can feel overwhelming, but at this stage, the cancer ...

In this segment, Ms. Popolo discusses the practical and logistical differences between intravenous and subcutaneous ...

CURE ® readers have a unique opportunity each year to honor oncology nurses who have helped guide them through the cancer experience. Many thoughtful nomination essays are prepared and submitted by ...

Attending meetings like the SGO Annual Meeting on Women's Cancer is driven by a shared commitment to patients and advancing ...

Meetings like SGO drive collaboration and patient-centered progress, as Dr. Ginger J. Gardner highlights their role in advancing access and research.

Dr. Bizekis emphasized that ongoing heartburn should not be ignored. For patients with persistent reflux, speaking with a doctor and considering further evaluation, such as an endoscopy, can help ...

Testicular cancer awareness messaging should target men aged 15–35 and emphasize that early detection materially improves ...

PYNNACLE enrolled heavily pretreated TP53 Y220C–mutant ovarian cancer (median four prior lines), including platinum-resistant ...